| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |